ConductScience.org, home

Paper5658197

Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts.

Heimpel H and 1 other. Helv Med Acta, 1968. Cited by 214 papers, by iCite.

Cite this record

ConductScience Library. Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts. Papers, record 5658197. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5658197

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts.
PubMed
Journal
Helv Med Acta
PubMed
Year
1968
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
214
iCite
Revised in PubMed
2015-11-19
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heimpel HH
2Wendt FF

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anemia, AplasticMajor topic
Cell NucleusMajor topic
Erythrocytes, AbnormalMajor topic
ErythropoiesisMajor topic
Adolescent
Adult
Bone Marrow
Bone Marrow Cells
Bone Marrow Examination
Chromium Isotopes
Humans
Iron Isotopes
Male

Source PubMed

Download CSV of topics

Cited by47

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 214 citations.

PMIDTitleJournalYearIn PapersSource
41028447Codanin-1, defective in congenital dyserythropoietic anemia I (CDA-I), regulates erythroid differentiation.Ann Hematol2025https://conductscience.org/library/papers/41028447PubMed
38765414Congenital Dyserythropoietic Anemia Type II With Myelofibrosis in an Adult Patient: A Report of a Rare Case With a Brief Review.Cureus2024https://conductscience.org/library/papers/38765414PubMed
36742183Ultrastructural characteristics of erythroid cells in congenital dyserythropoietic anemia type II, with a focus on peripheral cisternae and double membranes.Blood Sci2023https://conductscience.org/library/papers/36742183PubMed
35605178Inherited bone marrow failure in the pediatric patient.Blood2022https://conductscience.org/library/papers/35605178PubMed
33401150Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).Blood Cells Mol Dis2021https://conductscience.org/library/papers/33401150PubMed
33186543VPS4A Mutations in Humans Cause Syndromic Congenital Dyserythropoietic Anemia due to Cytokinesis and Trafficking Defects.Am J Hum Genet2020https://conductscience.org/library/papers/33186543PubMed
32518175Genetic and functional insights into CDA-I prevalence and pathogenesis.J Med Genet2021https://conductscience.org/library/papers/32518175PubMed
32239177A complex comprising C15ORF41 and Codanin-1: the products of two genes mutated in congenital dyserythropoietic anaemia type I (CDA-I).Biochem J2020https://conductscience.org/library/papers/32239177PubMed
30836435The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I.Br J Haematol2019https://conductscience.org/library/papers/30836435PubMed
29936674Whole-exome analysis to detect congenital hemolytic anemia mimicking congenital dyserythropoietic anemia.Int J Hematol2018https://conductscience.org/library/papers/29936674PubMed
23940284Congenital dyserythropoietic anemias: molecular insights and diagnostic approach.Blood2013https://conductscience.org/library/papers/23940284PubMed
23716552Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.Haematologica2013https://conductscience.org/library/papers/23716552PubMed
23065504Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach.Haematologica2012https://conductscience.org/library/papers/23065504PubMed
22696622Congenital dyserythropoietic anaemia type II: a rare entity.BMJ Case Rep2011https://conductscience.org/library/papers/22696622PubMed
22586181The COPII pathway and hematologic disease.Blood2012https://conductscience.org/library/papers/22586181PubMed
21850656Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population.Am J Hematol2011https://conductscience.org/library/papers/21850656PubMed
20421275The morphological diagnosis of congenital dyserythropoietic anemia: results of a quantitative analysis of peripheral blood and bone marrow cells.Haematologica2010https://conductscience.org/library/papers/20421275PubMed
19561605Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II.Nat Genet2009https://conductscience.org/library/papers/19561605PubMed
19336738Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated.Haematologica2009https://conductscience.org/library/papers/19336738PubMed
18824595Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.Blood2008https://conductscience.org/library/papers/18824595PubMed

See all 47 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5658197

GET https://conductscience.org/api/papers/v1/5658197/cited_by?page=2